These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26340130)

  • 1. First-in-man unprotected left main stenting with Stentys Xposition S self-apposing sirolimus eluting stent and optical coherence tomography guidance: The emerging panacea for left main intervention.
    Yew KL; Kang Z
    Int J Cardiol; 2015 Dec; 201():628-30. PubMed ID: 26340130
    [No Abstract]   [Full Text] [Related]  

  • 2. Early experience of transradial multivessel percutaneous coronary intervention with new generation STENTYS sirolimus eluting self-apposing stents for ectatic coronary arteries.
    Yew KL
    Int J Cardiol; 2015 Apr; 185():155-6. PubMed ID: 25795209
    [No Abstract]   [Full Text] [Related]  

  • 3. Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.
    Naganuma T; Fujino Y; Tahara S; Mitomo S; Basavarajaiah S; Nakamura S
    JACC Cardiovasc Interv; 2015 Dec; 8(14):e237-9. PubMed ID: 26718525
    [No Abstract]   [Full Text] [Related]  

  • 4. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
    Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
    Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Optical Coherence Tomography in the Assessment of Stent Deformation.
    Abdel-Hadi H; Shah AH; Džavík V
    Can J Cardiol; 2016 Mar; 32(3):396.e1-2. PubMed ID: 26921163
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of new sirolimus self-apposing stent in coronary interventions.
    Giustino G; Mehran R
    Minerva Cardioangiol; 2015 Feb; 63(1):45-57. PubMed ID: 25502188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.
    Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT
    EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
    Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
    EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis.
    Buccheri D; Orrego PS; Cortese B
    Int J Cardiol; 2015 Nov; 199():119-20. PubMed ID: 26188831
    [No Abstract]   [Full Text] [Related]  

  • 14. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Räber L; Regar E; Okamura T; di Mario C; van Es GA; Windecker S; Serruys PW
    Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete stent apposition and very late stent thrombosis after everolimus eluting stent implantation and dual antiplatelet therapy interruption. A case of OCT guided therapy.
    Gatto P; Dumonteil N; Boudou N; Van Rothem J; Lhermusier T; Bartorelli A; Carrié D
    Int J Cardiol; 2015 Feb; 180():52-4. PubMed ID: 25438210
    [No Abstract]   [Full Text] [Related]  

  • 17. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
    Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
    EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy.
    Terashita D; Otake H; Shinke T; Murasato Y; Kinoshita Y; Yamawaki M; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K; Hirata K
    Can J Cardiol; 2016 Mar; 32(3):384-90. PubMed ID: 26481078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.
    Biscaglia S; Secco GG; Tumscitz C; Di Mario C; Campo G
    Int J Cardiol; 2015 Mar; 182():1-3. PubMed ID: 25590956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.